Clinical Scorecard: AF Stroke Prevention: Testing Ablation
At a Glance
Category
Detail
Condition
Atrial Fibrillation with Recent Ischemic Stroke
Key Mechanisms
Catheter ablation combined with anticoagulation therapy
Target Population
Patients aged 20 to 85 years with nonvalvular atrial fibrillation and ischemic stroke within the previous 6 months
Care Setting
Outpatient settings in Japan
Key Highlights
No significant reduction in recurrent stroke or major cardiovascular outcomes with catheter ablation added to anticoagulation therapy, including recurrent ischemic stroke, systemic embolism, all-cause death, or hospitalization for heart failure.
Guideline-Based Recommendations
Diagnosis
Management
Standard therapy with edoxaban for anticoagulation
Consideration of catheter ablation after at least 4 weeks of edoxaban therapy, ideally performed within 1 to 6 months after stroke onset.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
249 patients enrolled in the STABLED trial
Standard therapy with edoxaban showed comparable outcomes to catheter ablation in terms of recurrent ischemic stroke and other major events.
Clinical Best Practices
Utilize direct oral anticoagulants for stroke prevention in atrial fibrillation.
Evaluate individual patient risk factors before considering catheter ablation.
Educate patients on the risks associated with both anticoagulation and catheter ablation.
